✦ LIBER ✦

Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab : The NEAR trial

✍ Scribed by Alexandra D. Jensen; Marc W. Münter; Helge G. Bischoff; Renate Haselmann; Uwe Haberkorn; Peter E. Huber; Michael Thomas; Jürgen Debus; Klaus K. Herfarth

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 272 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25888

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l